Dose volume effects of re‐irradiation for locally recurrent nasopharyngeal carcinoma

Background This study analyzed the dose volume effects of re‐irradiation for locally recurrent nasopharyngeal carcinoma (NPC) and attempts to determine the optimal dose for the best survival. Methods Ninety‐one patients were studied. The local control, fatal complication, and overall survival were a...

Full description

Saved in:
Bibliographic Details
Published in:Head & neck Vol. 42; no. 2; pp. 180 - 187
Main Authors: Ng, Wai‐Tong, Lee, Michael CH, Fung, Nelson TC, Wong, Edwin CY, Cheung, Alice KW, Chow, James CH, Au, Kwok‐Hung, Poon, Darren MC, Lai, Jessica WY, Chiang, Chi‐Leung, Choi, Horace CW, Chau, Tin‐Ching, Lee, Victor HF, Lee, Anne WM
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 01-02-2020
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background This study analyzed the dose volume effects of re‐irradiation for locally recurrent nasopharyngeal carcinoma (NPC) and attempts to determine the optimal dose for the best survival. Methods Ninety‐one patients were studied. The local control, fatal complication, and overall survival were analyzed against the dose (in Equivalent Dose at 2 Gy/fractions) and recurrent gross tumor volume (GTV). Results The local control and fatal complication rate appear to increase with prescribed dose. The overall survival peaks at around 60 Gy10. Local control decreases significantly with increasing GTV (P < .001) while overall survival shows similar trend (P = .06). No correlation was observed between the fatal complication rate and GTV volume. The dose response of local control appears to be stronger for smaller tumors. Conclusion GTV volume plays a significant role in local control. A 60 Gy10 appears to be optimal for the best survival outcome; higher doses might be considered for small tumors.
Bibliography:Funding information
Health and Medical Research Fund, Grant/Award Number: 15163081
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.25988